Bank of New York Mellon’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-26,311
Closed -$8.58K 4415
2023
Q2
$8.58K Sell
26,311
-10,251
-28% -$3.34K ﹤0.01% 4339
2023
Q1
$15.7K Sell
36,562
-100
-0.3% -$43 ﹤0.01% 4325
2022
Q4
$19.4K Sell
36,662
-81
-0.2% -$43 ﹤0.01% 4360
2022
Q3
$27K Buy
36,743
+100
+0.3% +$73 ﹤0.01% 4408
2022
Q2
$42K Sell
36,643
-70
-0.2% -$80 ﹤0.01% 4383
2022
Q1
$75K Hold
36,713
﹤0.01% 4457
2021
Q4
$106K Hold
36,713
﹤0.01% 4393
2021
Q3
$156K Buy
36,713
+17,056
+87% +$72.5K ﹤0.01% 4249
2021
Q2
$104K Sell
19,657
-1,895
-9% -$10K ﹤0.01% 4207
2021
Q1
$100K Sell
21,552
-1,902
-8% -$8.83K ﹤0.01% 4163
2020
Q4
$77K Buy
23,454
+13,288
+131% +$43.6K ﹤0.01% 4110
2020
Q3
$34K Buy
10,166
+1
+0% +$3 ﹤0.01% 4055
2020
Q2
$34K Sell
10,165
-53,290
-84% -$178K ﹤0.01% 4020
2020
Q1
$243K Sell
63,455
-4,546
-7% -$17.4K ﹤0.01% 3674
2019
Q4
$411K Buy
68,001
+6,544
+11% +$39.6K ﹤0.01% 3684
2019
Q3
$464K Buy
61,457
+3,159
+5% +$23.9K ﹤0.01% 3573
2019
Q2
$789K Buy
+58,298
New +$789K ﹤0.01% 3358
2018
Q2
Sell
-33,319
Closed -$290K 4314
2018
Q1
$290K Buy
33,319
+1,504
+5% +$13.1K ﹤0.01% 3800
2017
Q4
$398K Sell
31,815
-4,251
-12% -$53.2K ﹤0.01% 3695
2017
Q3
$301K Buy
36,066
+537
+2% +$4.48K ﹤0.01% 3756
2017
Q2
$602K Buy
35,529
+23,364
+192% +$396K ﹤0.01% 3516
2017
Q1
$245K Buy
12,165
+635
+6% +$12.8K ﹤0.01% 3809
2016
Q4
$180K Buy
+11,530
New +$180K ﹤0.01% 3919
2016
Q3
Sell
-10,129
Closed -$69K 4321
2016
Q2
$69K Buy
+10,129
New +$69K ﹤0.01% 4124